Smart Pills were first approved for human use in 2017 by the Food and Drug Administration for schizophrenic, bipolar and major depressive drug usage. It is estimated that Smart Pills could save $100-$300 billion annually in the US, however there are still apprehension about the use of the drug. There is still no concrete evidence suggesting that Smart Pills benefit patients and may even challenge the ingenuity of patients.
“Researchers at the University of Illinois in Chicago have warned health care provider and policymakers to ‘slow down’ when it comes to allowing this technology in patient care settings.
Smart pills, also known as digital pill, are medications prescribed to patients that are equipped with edible electronic sensors that send wireless message to devices like patches, tablets or smartphones outside the body when they are ingested” Via European Pharmaceutical Review